• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体化噬菌体疗法治疗泛耐药性脊柱铜绿假单胞菌感染。

Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.

机构信息

Service de Maladies Infectieuses et Tropicales, Hôpital de la Croix-rousse, Hospices Civils de Lyon, Lyon, France.

Université Claude Bernard Lyon 1, Villeurbanne, France.

出版信息

Nat Commun. 2022 Jul 22;13(1):4239. doi: 10.1038/s41467-022-31837-9.

DOI:10.1038/s41467-022-31837-9
PMID:35869081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9306240/
Abstract

Bone and joint infections (BJI) are one of the most difficult-to-treat bacterial infection, especially in the era of antimicrobial resistance. Lytic bacteriophages (phages for short) are natural viruses that can selectively target and kill bacteria. They are considered to have a high therapeutic potential for the treatment of severe bacterial infections and especially BJI, as they also target biofilms. Here we report on the management of a patient with a pandrug-resistant Pseudomonas aeruginosa spinal abscess who was treated with surgery and a personalized combination of phage therapy that was added to antibiotics. As the infecting P. aeruginosa strain was resistant to the phages developed by private companies that were contacted, we set up a unique European academic collaboration to find, produce and administer a personalized phage cocktail to the patient in due time. After two surgeries, despite bacterial persistence with expression of small colony variants, the patient healed with local and intravenous injections of purified phages as adjuvant therapy.

摘要

骨和关节感染(BJI)是最难治疗的细菌感染之一,尤其是在抗微生物药物耐药性的时代。溶菌噬菌体(简称噬菌体)是可以选择性地靶向和杀死细菌的天然病毒。它们被认为具有治疗严重细菌感染的高治疗潜力,特别是 BJI,因为它们也针对生物膜。在这里,我们报告了一例使用噬菌体治疗联合手术治疗泛耐药铜绿假单胞菌脊柱脓肿患者的情况。由于感染的铜绿假单胞菌菌株对联系的私人公司开发的噬菌体具有耐药性,我们建立了一个独特的欧洲学术合作关系,以便及时为患者找到、生产和管理个性化的噬菌体鸡尾酒。尽管两次手术后仍有小菌落变体表达的细菌持续存在,但患者通过局部和静脉注射纯化噬菌体作为辅助治疗而痊愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/3c89835a721e/41467_2022_31837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/c3ebabd1f603/41467_2022_31837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/aa73ee4e71f9/41467_2022_31837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/3c89835a721e/41467_2022_31837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/c3ebabd1f603/41467_2022_31837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/aa73ee4e71f9/41467_2022_31837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/9307588/3c89835a721e/41467_2022_31837_Fig3_HTML.jpg

相似文献

1
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.个体化噬菌体疗法治疗泛耐药性脊柱铜绿假单胞菌感染。
Nat Commun. 2022 Jul 22;13(1):4239. doi: 10.1038/s41467-022-31837-9.
2
Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.设计一种广谱噬菌体鸡尾酒,减少铜绿假单胞菌生物膜并在两种动物模型中治疗急性感染。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.02573-17. Print 2018 Jun.
3
Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant and Enhance Sensitivity to Carbapenem Antibiotics.噬菌体组合对多药耐药菌有效,并增强对碳青霉烯类抗生素的敏感性。
Viruses. 2024 Jun 21;16(7):1000. doi: 10.3390/v16071000.
4
Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.三种具有治疗潜力的铜绿假单胞菌病毒的分离与鉴定。
Microbiol Spectr. 2023 Jun 15;11(3):e0463622. doi: 10.1128/spectrum.04636-22. Epub 2023 May 1.
5
Identification and impact on virulence of mutations conferring resistance to a phage cocktail for phage therapy.鉴定和评估噬菌体鸡尾酒耐药突变对噬菌体治疗的毒力影响
Microbiol Spectr. 2023 Dec 12;11(6):e0147723. doi: 10.1128/spectrum.01477-23. Epub 2023 Nov 15.
6
Optimizing bacteriophage treatment of resistant .优化噬菌体治疗耐药菌。
mSphere. 2024 Jul 30;9(7):e0070723. doi: 10.1128/msphere.00707-23. Epub 2024 Jun 27.
7
Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.噬菌体疗法对细菌性马角膜炎小鼠模型有效。
Appl Environ Microbiol. 2016 Aug 15;82(17):5332-9. doi: 10.1128/AEM.01166-16. Print 2016 Sep 1.
8
Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs.利用噬菌体耐药权衡开发经过进化训练的噬菌体鸡尾酒靶向铜绿假单胞菌生物膜。
Nat Commun. 2024 Oct 3;15(1):8572. doi: 10.1038/s41467-024-52595-w.
9
Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Left Ventricular Assist Device Driveline Infection.成功的噬菌体-抗生素联合治疗策略对抗多重耐药性左心室辅助装置带感染
Viruses. 2023 May 20;15(5):1210. doi: 10.3390/v15051210.
10
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.噬菌体鸡尾酒治疗绿脓杆菌感染烧伤创面的疗效和耐受性(PhagoBurn):一项随机、对照、双盲 1/2 期试验。
Lancet Infect Dis. 2019 Jan;19(1):35-45. doi: 10.1016/S1473-3099(18)30482-1. Epub 2018 Oct 3.

引用本文的文献

1
Nanocoated bacterial carriers enhance oral bacteriophage delivery efficiency.纳米涂层细菌载体提高口服噬菌体递送效率。
Acta Pharm Sin B. 2025 Aug;15(8):4319-4321. doi: 10.1016/j.apsb.2025.05.037. Epub 2025 Jun 3.
2
Biocontrol of Phage Resistance in Infections: Insights into Directed Breaking of Spontaneous Evolutionary Selection in Phage Therapy.感染中噬菌体抗性的生物防治:噬菌体疗法中定向打破自发进化选择的见解
Viruses. 2025 Aug 4;17(8):1080. doi: 10.3390/v17081080.
3
Lytic bacteriophages targeting multidrug-resistant Pseudomonas aeruginosa in Moschus berezovskii: isolation, characterization, and therapeutic efficacy against bacteremia.

本文引用的文献

1
A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety.噬菌体疗法应用于骨与关节感染的系统评价:成功率、治疗方式及安全性分析
EFORT Open Rev. 2021 Dec 10;6(12):1148-1156. doi: 10.1302/2058-5241.6.210073. eCollection 2021 Dec.
2
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection.噬菌体治疗和噬菌体衍生蛋白在骨和关节感染患者中的过去和未来。
Viruses. 2021 Dec 2;13(12):2414. doi: 10.3390/v13122414.
3
Recent progress toward the implementation of phage therapy in Western medicine.
靶向马麝体内耐多药铜绿假单胞菌的裂解性噬菌体:分离、鉴定及对菌血症的治疗效果
Virol J. 2025 Aug 19;22(1):285. doi: 10.1186/s12985-025-02715-9.
4
Characterization, Genomic Analysis and Application of Five Lytic Phages Against Carbapenem-Resistant .五种针对耐碳青霉烯类细菌的裂解性噬菌体的特性、基因组分析及应用
Microorganisms. 2025 Jul 5;13(7):1587. doi: 10.3390/microorganisms13071587.
5
Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.噬菌体和溶菌酶治疗耐药细菌:从实验室到临床应用
MedComm (2020). 2025 Jul 13;6(7):e70280. doi: 10.1002/mco2.70280. eCollection 2025 Jul.
6
Insight into Bacteriophage Therapy for Bacterial Infections and Cancer.对噬菌体疗法治疗细菌感染和癌症的见解。
Mol Biotechnol. 2025 Jul 9. doi: 10.1007/s12033-025-01466-w.
7
Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages.多重耐药性胃肠道感染的非抗生素疗法:益生菌、天然化合物和噬菌体的应用概述
Front Antibiot. 2025 May 6;4:1554061. doi: 10.3389/frabi.2025.1554061. eCollection 2025.
8
Deciphering Multidrug-Resistant : Mechanistic Insights and Environmental Risks.解读多重耐药性:机制洞察与环境风险
Toxics. 2025 Apr 12;13(4):303. doi: 10.3390/toxics13040303.
9
Automation of a Capillary-Wave Microbioreactor Platform to Enhance Phage Sensitivity Screen Efficiency.毛细管波微生物反应器平台的自动化以提高噬菌体敏感性筛选效率。
Eng Life Sci. 2025 Apr 14;25(4):e70021. doi: 10.1002/elsc.70021. eCollection 2025 Apr.
10
Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections.在集中化与碎片化之间:噬菌体保藏的过去、现在与未来
Phage (New Rochelle). 2024 Mar 18;5(1):22-29. doi: 10.1089/phage.2023.0043. eCollection 2024 Mar.
近年来,噬菌体疗法在西方医学中的应用取得了进展。
FEMS Microbiol Rev. 2022 Jan 18;46(1). doi: 10.1093/femsre/fuab040.
4
Case Report: Arthroscopic "Debridement Antibiotics and Implant Retention" With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Prosthetic Knee Infection.病例报告:关节镜下“清创、抗生素治疗及植入物保留”联合局部注射个性化噬菌体疗法挽救复发性人工膝关节感染
Front Med (Lausanne). 2021 May 5;8:569159. doi: 10.3389/fmed.2021.569159. eCollection 2021.
5
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol.严重且难治性感染的负担以及一种新型抗生素——头孢地尔的问世
Front Pharmacol. 2021 Jan 14;11:578823. doi: 10.3389/fphar.2020.578823. eCollection 2020.
6
Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France.植入物相关的骨与关节感染:法国某地区参考中心的经验
Front Med (Lausanne). 2020 Oct 26;7:513242. doi: 10.3389/fmed.2020.513242. eCollection 2020.
7
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.噬菌体治疗铜绿假单胞菌生物膜:综述。
Ann Clin Microbiol Antimicrob. 2020 Sep 30;19(1):45. doi: 10.1186/s12941-020-00389-5.
8
Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.头孢地尔单独及与左氧氟沙星、米诺环素、多粘菌素B或复方磺胺甲恶唑联合使用对多重耐药嗜麦芽窄食单胞菌的活性。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00559-20.
9
Current challenges and future opportunities of phage therapy.噬菌体疗法的当前挑战与未来机遇
FEMS Microbiol Rev. 2020 Nov 24;44(6):684-700. doi: 10.1093/femsre/fuaa017.
10
Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study.脊柱植入物相关感染采用或不采用抗生物膜抗生素治疗的结果:一项为期 10 年的队列研究结果。
Infection. 2020 Aug;48(4):559-568. doi: 10.1007/s15010-020-01435-2. Epub 2020 May 5.